Research progress and design optimization of CAR‐T therapy for pancreatic ductal adenocarcinoma

Pancreatic ductal adenocarcinoma (PDAC) is a highly malignant cancer with limited treatment options. Chimeric antigen receptor T cells (CAR‐T) are genetically engineered T cells that can specifically kill tumor cells without major histocompatibility complex restriction. Encouraging progress in CAR‐T...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cancer Med
Main Authors: Li, Tianjiao, Li, Hao, Li, Shuo, Xu, Shuaishuai, Zhang, Wuhu, Gao, Heli, Xu, Huaxiang, Wu, Chuntao, Wang, Wenquan, Yu, Xianjun, Liu, Liang
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley and Sons Inc. 2019
Assuntos:
Cancer Biology
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6718528/
https://ncbi.nlm.nih.gov/pubmed/31339230
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cam4.2430
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados